NYSE:ALB

Albemarle is a global specialty chemical company focusing on lithium, bromine and refining catalysts. The company develops, manufactures, and markets highly-engineered specialty chemicals. It is the industry leader in lithium and lithium derivatives. Albemarle is a globally diversified company with low-cost resources and an integrated product portfolio. It operates 29 production and R&D facilities. Albemarle’s reportable segments are lithium (36% of net sales), bromine specialties (29%) and catalysts (31%). It currently owns nearly 2,100 active patents and 600 pending patent applications in key strategic markets worldwide. The company supplies power to companies in a wide range of industries like energy, communications, transportation, and electronics, etc. Albemarle serves over 2,300 customers and has a presence in more than 100 countries worldwide. The company engages in developing value-added and customized solutions for its clients. Albemarle’s unique natural resource position, derivatization capabilities, and technology leadership are its strong competitive advantages. The company is favorably placed to gain from the growing lithium demand underpinned by energy efficiency macro drivers.